Reference health
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma
33/33 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 33 checked references that resolve
resolves10.1016/j.ctrv.2010.11.004
Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: Where do we stand?
resolves10.1309/AJCPVAGIUC1AHC3Y
Epidermal Growth Factor Receptor Gene Analysis With a Highly Sensitive Molecular Assay in Routine Cytologic Specimens of Lung Adenocarcinoma
resolves10.1016/j.bcp.2011.07.073
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets
resolves10.1046/j.1365-2559.2000.00793.x
MIB‐1 proliferation index correlates with survival in pleural malignant mesothelioma
resolves10.1002/ijc.21271
CommonEGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma
resolves10.1200/JCO.1998.16.1.145
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
resolves10.1038/bjc.1990.207
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody
resolves10.1200/JCO.2008.18.0786
Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
resolves10.1016/j.lungcan.2005.08.009
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay
resolves10.1136/jclinpath-2011-200631
Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma
resolves10.1245/s10434-008-0206-6
Novel and Existing Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor are Predictors of Optimal Resectability in Malignant Peritoneal Mesothelioma
resolves10.1186/1477-7819-8-88
Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma
resolves10.1200/JCO.2006.09.7634
Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study
resolves10.1097/JTO.0b013e3182629903
A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
resolves10.1158/1078-0432.CCR-04-1940
Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B
resolves10.3892/ijo.2012.1607
Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
resolves10.1158/0008-5472.CAN-06-0191
<i>KRAS</i> Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
resolves10.1158/1078-0432.CCR-10-3137
Increased Detection Sensitivity for <i>KRAS</i> Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
resolves10.1097/00000421-198212000-00014
Toxicity and response criteria of the Eastern Cooperative Oncology Group
resolves10.1007/s00432-008-0384-4
Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma
resolves10.1126/science.1099314
<i>EGFR</i>
Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
resolves10.1097/JTO.0b013e3181f1c8de
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
resolves10.1002/jso.21901
Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: Prognostic correlations
resolves10.1158/0008-5472.CAN-08-2466
<i>PIK3CA</i>
Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
resolves10.1097/JTO.0b013e31819c8661
Absence of Mutations in the Epidermal Growth Factor Receptor (EGFR) Kinase Domain in Patients with Mesothelioma
resolves10.1200/JCO.2003.11.136
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
The 6 references without a DOI — listed, not checked
no DOI — not checkedLanphear BP, Buncher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34: 718–721.
no DOI — not checkedPache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB, Taatjes DJ, Mossman BT (1998) Increased epidermal growth-factor receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am J Pathol 152: 333–340.
no DOI — not checkedSobin LH, Gospodarowic MK, Wittekind (2009) TNM Classification of Malignant Tumours 7th edn. pp 142–145. Wiley-Blackwell: Oxford, UK.
no DOI — not checkedSuzuki Y, Murakami H, Kawaguchi K, Tanigushi T, Fujii M, Shinjo K, Kondo Y, Osada H, Shimokata K, Horio Y, Hasegawa Y, Hida T, Sekido Y (2009) Activation of the PI3K-AKT pathway in human malignant mesothelioma cells. Mol Med Report 2: 181–188.
no DOI — not checkedTravis WD, Brambilla E, Mueller-Hermelink HK, Harris CC (2004) World Health Organization Classification of tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart pp 125–136. IARC Press: Lyon, France.
no DOI — not checkedWagner JC, Sleggs P, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17: 260–271.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/bjc.2013.130"><img src="https://citestamp.com/citestamped/10.1038/bjc.2013.130/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/bjc.2013.130)